LNTH Lantheus to Buy Evergreen Theragnostics Lantheus Holdings, Inc. (NASDAQ:LNTH) announced its second acquisition this ...

Lantheus Holdings, Inc. (NASDAQ:LNTH) agreed to acquire Evergreen Theragnostics, Inc. in an all-cash transaction involving an ...

Radiopharmaceutical specialist Lantheus Holdings (NASDAQ: LNTH) had some news to report Tuesday morning, but the market ...

Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LNTH stock, giving a Buy rating yesterday.Invest with Confidence: ...

Lantheus Holdings Inc. is adding to its portfolio yet again, acquiring a clinical-stage radiopharmaceutical company in a deal ...

Lantheus (LNTH) announced the appointment of Phuong Khanh Morrow, M.D. to Lantheus’ Board of Directors, effective February 1, 2025. As an ...

Massachusetts-based radiopharmaceutical company Lantheus (Nasdaq: LNTH) has announced a plan to acquire clinical-stage ...

Lantheus Holdings, Inc. (LNTH) stock price is 91.13 and Lantheus Holdings, Inc. (LNTH) 10-day simple moving average is 94.66. Lantheus Holdings, Inc. (LNTH) stock price is 91.13 and Lantheus ...

Lantheus ( ($LNTH) ) has shared an update. On January 27, 2025, Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, announced an ...

Lantheus Holdings, Inc. (NASDAQ:LNTH – Get Free Report) has received a consensus recommendation of “Buy” from the seven analysts that are presently covering the firm, MarketBeat reports. Seven ...

LNTH has 3 products PLYARIFY, DEFINITY, and TechneLite, all of which are very successful. From my research, I think LTNH can easily become a $200+ stock in the next 3–5 years, which I why I'm ...

Short interest in Lantheus Holdings Inc (NASDAQ:LNTH) increased during the last reporting period, rising from 4.68M to 6.19M. This put 11.76% of the company's publicly available shares short.